Researchers at the University of Colorado Anschutz Medical Campus have discovered that inhibiting the Mdm2 protein with a drug called nutlin prevents the synaptic destruction associated with Alzheimer’s disease, offering a promising new avenue for therapy. This approach, which diverges from traditional strategies focusing on amyloid plaque removal, could potentially halt the disease’s progression and is set to undergo further testing in animal models.
#scientists-develop-potential-new-method-to-halt-progression-of-alzheimers-disease
#scitechdaily.com
SciTechDaily
201 ngày
